240 related articles for article (PubMed ID: 32072336)
21. Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.
Gozes I; Van Dijck A; Hacohen-Kleiman G; Grigg I; Karmon G; Giladi E; Eger M; Gabet Y; Pasmanik-Chor M; Cappuyns E; Elpeleg O; Kooy RF; Bedrosian-Sermone S
Transl Psychiatry; 2017 Feb; 7(2):e1043. PubMed ID: 28221363
[TBL] [Abstract][Full Text] [Related]
22. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
[TBL] [Abstract][Full Text] [Related]
23. VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive
Sragovich S; Amram N; Yeheskel A; Gozes I
Front Cell Neurosci; 2019; 13():589. PubMed ID: 31992971
[TBL] [Abstract][Full Text] [Related]
24. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
Gozes I
Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal Genotype-Phenotype (Vineland Questionnaire) Characterization of 15 ADNP Syndrome Cases Highlights Mutated Protein Length and Structural Characteristics Correlation with Communicative Abilities Accentuated in Males.
Levine J; Lobyntseva A; Shazman S; Hakim F; Gozes I
J Mol Neurosci; 2024 Jan; 74(1):15. PubMed ID: 38282129
[TBL] [Abstract][Full Text] [Related]
26. Cellular and animal models of skin alterations in the autism-related ADNP syndrome.
Mollinedo P; Kapitansky O; Gonzalez-Lamuño D; Zaslavsky A; Real P; Gozes I; Gandarillas A; Fernandez-Luna JL
Sci Rep; 2019 Jan; 9(1):736. PubMed ID: 30679581
[TBL] [Abstract][Full Text] [Related]
27. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
[TBL] [Abstract][Full Text] [Related]
28. The autism spectrum phenotype in ADNP syndrome.
Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
[TBL] [Abstract][Full Text] [Related]
29. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
Gozes I
Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota profile in healthy Indonesians.
Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
[TBL] [Abstract][Full Text] [Related]
31. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.
Ivashko-Pachima Y; Maor-Nof M; Gozes I
PLoS One; 2019; 14(3):e0213666. PubMed ID: 30865715
[TBL] [Abstract][Full Text] [Related]
32. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
[TBL] [Abstract][Full Text] [Related]
33. Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain.
Hacohen-Kleiman G; Yizhar-Barnea O; Touloumi O; Lagoudaki R; Avraham KB; Grigoriadis N; Gozes I
Neurochem Res; 2019 Jun; 44(6):1494-1507. PubMed ID: 30659505
[TBL] [Abstract][Full Text] [Related]
34. Sex-and Region-Dependent Expression of the Autism-Linked ADNP Correlates with Social- and Speech-Related Genes in the Canary Brain.
Hacohen-Kleiman G; Moaraf S; Kapitansky O; Gozes I
J Mol Neurosci; 2020 Nov; 70(11):1671-1683. PubMed ID: 32926339
[TBL] [Abstract][Full Text] [Related]
35. Sensory Reactivity Symptoms Are a Core Feature of ADNP Syndrome Irrespective of Autism Diagnosis.
Siper PM; Layton C; Levy T; Lurie S; Benrey N; Zweifach J; Rowe M; Tang L; Guillory S; Halpern D; Giserman-Kiss I; Del Pilar Trelles M; Foss-Feig JH; De Rubeis S; Tavassoli T; Buxbaum JD; Kolevzon A
Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33673501
[No Abstract] [Full Text] [Related]
36. ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease.
Sragovich S; Merenlender-Wagner A; Gozes I
Bioessays; 2017 Nov; 39(11):. PubMed ID: 28940660
[TBL] [Abstract][Full Text] [Related]
37. Deciphering the Enigma: NAP (CP201) the Active ADNP Drug Candidate Enters Cells by Dynamin-Associated Endocytosis.
Ivashko-Pachima Y; Gozes I
J Mol Neurosci; 2020 Jul; 70(7):993-998. PubMed ID: 32588400
[No Abstract] [Full Text] [Related]
38. ADNP: A major autism mutated gene is differentially distributed (age and gender) in the songbird brain.
Hacohen Kleiman G; Barnea A; Gozes I
Peptides; 2015 Oct; 72():75-9. PubMed ID: 25895853
[TBL] [Abstract][Full Text] [Related]
39. NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms.
Ganaiem M; Gildor ND; Shazman S; Karmon G; Ivashko-Pachima Y; Gozes I
Cells; 2023 Sep; 12(18):. PubMed ID: 37759476
[TBL] [Abstract][Full Text] [Related]
40. Activity-dependent neuroprotective protein: from gene to drug candidate.
Gozes I
Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
